METABOLOMIC BIOMARKERS PREDICT MAJOR ADVERSE CARDIOVASCULAR EVENTS, LONG-TERM POST-COVID CONDITIONS, AND DEATH IN PATIENTS WITH COVID-19.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request